Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KISS1R | Q969F8 | 16/20 | 0.61 |
| ▸ | IL23R | Q5VWK5 | 4/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29639691 | 1.00 | KISS1R (0.61) | KISS1RIL23R | |
| SCHEMBL31672259 | 0.95 | KISS1R (0.65) | KISS1RIL23R | |
| SCHEMBL29639696 | 0.95 | IL23R (0.55) | KISS1RIL23R | |
| SCHEMBL16768932 | 0.95 | IL23R (0.60) | KISS1RIL23R | |
| SCHEMBL12262856 | 0.94 | KISS1R (0.61) | KISS1RIL23R | |
| SCHEMBL12262860 | 0.93 | KISS1R (0.60) | KISS1RIL23R | |
| SCHEMBL30476382 | 0.89 | KISS1R (0.59) | KISS1RIL23R | |
| SCHEMBL12262857 | 0.89 | ERBB2 (0.55) | KISS1RIL23R | |
| SCHEMBL12262858 | 0.88 | ERBB2 (0.56) | KISS1RIL23R | |
| SCHEMBL29794161 | 0.87 | ERAP2 (0.61) | KISS1RIL23R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11759509-B2 | WT1 antigen peptide conjugate vaccine | Sumitomo Pharma Co., Ltd. (JP) | 2023-09-19 | — | — | US | disclosed |
| EP-3199175-B1 | PHARMACEUTICAL COMPOSITION FOR INJECTION | SUMITOMO DAINIPPON PHARMA CO LTD (JP) | 2022-03-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11759509-B2 | WT1 antigen peptide conjugate vaccine | MICA, HLA-DRB1, HLA-B | KISS1R 865/4885IL23R 536/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.